Fairfield Financial Advisors, LTD Eli Lilly & CO Transaction History

Fairfield Financial Advisors, LTD

$294 Billion
Q3 2024

A detailed history of Fairfield Financial Advisors, LTD transactions in Eli Lilly & CO stock. As of the latest transaction made, Fairfield Financial Advisors, LTD holds 14,639 shares of LLY stock, worth $11.6 Million. This represents 4.41% of its overall portfolio holdings.

Number of Shares

14,639

Previous 14,210 3.02%

Holding current value

$11.6 Million

Previous $12.9 Billion 0.81%

% of portfolio

4.41%

Previous 3.79%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 28, 2024	BUY	$772.14 - $960.02 $331,248 - $411,848	429 Added 3.02%	14,639 $13 Billion
Q2 2024 Aug 09, 2024	BUY	$724.87 - $909.04 $10.3 Million - $12.9 Million	14,210 New	14,210 $12.9 Billion
Q4 2023 Nov 04, 2024	BUY	$525.19 - $619.13 $310,912 - $366,524	592 Added 4.36%	14,184 $8.27 Billion
Q3 2023 Nov 04, 2024	BUY	$434.7 - $599.3 $313,418 - $432,095	721 Added 5.6%	13,592 $7.3 Billion
Q2 2023 Nov 04, 2024	SELL	$350.74 - $468.98 $620,108 - $829,156	-1,768 Reduced 12.08%	12,871 $6.04 Billion
Q1 2023 Nov 04, 2024	SELL	$310.63 - $364.82 $956,119 - $1.12 Million	-3,078 Reduced 21.03%	11,561 $3.94 Billion
Q4 2022 Oct 07, 2024	BUY	$321.55 - $374.67 $72,027 - $83,926	224 Added 2.24%	10,239 $3.75 Billion
Q3 2022 Oct 07, 2024	SELL	$296.48 - $337.87 $1.24 Million - $1.42 Million	-4,195 Reduced 29.52%	10,015 $3.24 Billion
Q2 2022 Oct 07, 2024	SELL	$278.73 - $327.27 $1.41 Million - $1.65 Million	-5,041 Reduced 35.48%	9,169 $2.97 Billion
Q1 2022 Oct 07, 2024	SELL	$234.69 - $291.66 $1.21 Million - $1.5 Million	-5,160 Reduced 36.31%	9,050 $2.59 Billion

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $756B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fairfield Financial Advisors, LTD, based on Form 13F filings with the SEC.

News

Stay updated on Fairfield Financial Advisors, LTD with notifications on news.

Account

Fairfield Financial Advisors, LTD Eli Lilly & CO Transaction History